BioCryst Pharmaceuticals, Inc.

4505 Emperor Blvd Ste 200 , Durham, NC 27703

Public
Healthcare & Pharmaceuticals - Biotechnology
around $10 - 20M
around 100 - 250
(919) 859-1302
(919) 859-1314


BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas. Peramivir is its product, which is a neuraminidase inhibitor for the treatment of patients with influenza. The Company has two purine nucleoside phosphorylase (PNP) inhibitors that are in development, BCX4208 for the treatment of gout and forodesine for the treatment of hematological malignancies. The Company's pre-clinical compounds include BCX4161, an oral prophylactic drug for hereditary angioedema, and BCX5191, an adenine nucleoside analog targeting viral ribonucleic acid (RNA) polymerase for the treatment of hepatitis C.... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with BioCryst Pharmaceuticals, Inc.?




22 Contacts at this company
Jamie Gault
Director, Regulatory Operations and ...
Vivek Kamath
Director, Chemical Development ...
Lynne Powell
Chief Commercial Officer
Lance Walton
Vice President, Financial Reporting ...
Amanda Mathis
Director, Clinical Pharmacology
Pengcheng Lv
Research Scientist II
Bob Stoner
Vice President Human Resources
Christine Stanczak
Clinical Study Manager
Leslie Henry
Director, Intellectual Property

No company news available.
Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.